Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-1026
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of tofacitinib on the clinical features of periodontitis in patients with rheumatoid arthritis: two case reports ; volume:3 ; number:1 ; day:19 ; month:4 ; year:2019 ; pages:1-4 ; date:12.2019
BMC Rheumatology ; 3, Heft 1 (19.4.2019), 1-4, 12.2019
- Creator
-
Kobayashi, Tetsuo
Ito, Satoshi
Murasawa, Akira
Ishikawa, Hajime
Yoshie, Hiromasa
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41927-019-0062-y
- URN
-
urn:nbn:de:101:1-2019042321254971548396
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kobayashi, Tetsuo
- Ito, Satoshi
- Murasawa, Akira
- Ishikawa, Hajime
- Yoshie, Hiromasa
- SpringerLink (Online service)
Other Objects (12)
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Rheumatoide Arthritis: Kardiovaskuläre Komplikationen unter Tofacitinib
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Rheumatoide Arthritis: Kardiovaskuläre Komplikationen unter Tofacitinib
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Rheumatoide Arthritis: Kardiovaskuläre Komplikationen unter Tofacitinib